"Mucositis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).
| Descriptor ID |
D052016
|
| MeSH Number(s) |
C06.405.205.798 C07.465.584
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mucositis".
Below are MeSH descriptors whose meaning is more specific than "Mucositis".
This graph shows the total number of publications written about "Mucositis" by people in this website by year, and whether "Mucositis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 4 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mucositis" by people in Profiles.
-
Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection. JAMA Dermatol. 2021 05 01; 157(5):603-605.
-
Mucosal Respiratory Syndrome: A Systematic Literature Review. Dermatology. 2022; 238(1):53-59.
-
Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children. J Am Acad Dermatol. 2021 02; 84(2):408-414.
-
Cranial polyneuropathy as the first manifestation of a severe COVID-19 in a child. Pediatr Blood Cancer. 2021 03; 68(3):e28707.
-
Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content. Med Hypotheses. 2020 Oct; 143:110150.
-
Newer approaches in diagnosis of diarrhea in immunocompromised patients. Curr Opin Infect Dis. 2019 10; 32(5):461-467.
-
Skin adverse events in recently approved targeted therapies in solid malignancies. Future Oncol. 2019 Jan; 15(3):331-343.
-
Probiotics and mucositis. Curr Opin Clin Nutr Metab Care. 2018 09; 21(5):399-404.
-
True nature of mild epithelial dysplasia in oral lichenoid mucositis - Is it a reactionary change to the sub-epithelial inflammation or represents true malignant potential? A hypothesis. Med Hypotheses. 2018 11; 120:48.
-
Activation of Activin receptor-like kinases curbs mucosal inflammation and proliferation in chronic rhinosinusitis with nasal polyps. Sci Rep. 2018 01 24; 8(1):1561.